Topics
- Page Path
-
- HOME
- TOPICS
- Topics
- Editorial
- Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
- Joo Hyun Oh, Dong Hyun Sinn
- Clin Mol Hepatol. 2023;29(2):367-370. Published online March 20, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0054 Correction in: Clin Mol Hepatol 2023;29(3):828
-
View: 2552 Download: 65 Web of Science: 3 Crossref: 2
- The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
- Moon Haeng Hur, Jeong-Hoon Lee
- Clin Mol Hepatol. 2023;29(2):363-366. Published online March 9, 2023
-
View: 2742 Download: 86 Web of Science: 1 Crossref: 1
- The current trends in the health burden of primary liver cancer across the globe
- Peter Konyn, Aijaz Ahmed, Donghee Kim
- Clin Mol Hepatol. 2023;29(2):358-362. Published online March 14, 2023
-
View: 2924 Download: 63 Web of Science: 1 Crossref: 2
- The latest global burden of liver cancer: A past and present threat
- Joo Hyun Oh, Dae Won Jun
- Clin Mol Hepatol. 2023;29(2):355-357. Published online March 9, 2023
-
View: 3533 Download: 101 Web of Science: 14 Crossref: 21
- Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan
- San-Chi Chen
- Clin Mol Hepatol. 2023;29(2):352-354. Published online March 20, 2023
-
View: 2656 Download: 62
- Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
- Shen-Yung Wang
- Clin Mol Hepatol. 2023;29(2):349-351. Published online March 20, 2023
-
View: 2567 Download: 60
- The prime time for management of hepatocellular carcinoma in Hong Kong
- Landon L. Chan, Stephen L. Chan
- Clin Mol Hepatol. 2023;29(2):345-348. Published online March 9, 2023
-
View: 2546 Download: 55
- Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
- Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
- Clin Mol Hepatol. 2023;29(2):342-344. Published online March 16, 2023
-
View: 2924 Download: 64 Web of Science: 4 Crossref: 5
- The clinical management of hepatocellular carcinoma in China: Progress and challenges
- Shan Shan, Jidong Jia
- Clin Mol Hepatol. 2023;29(2):339-341. Published online March 16, 2023
-
View: 3054 Download: 99 Web of Science: 2 Crossref: 2
- Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
- Do Young Kim
- Clin Mol Hepatol. 2023;29(2):335-338. Published online March 20, 2023
-
View: 2721 Download: 54
- What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
- Min Kyung Park, Yoon Jun Kim
- Clin Mol Hepatol. 2023;29(2):332-334. Published online March 16, 2023
-
View: 2486 Download: 49
- Review
- Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
- Shang-Chin Huang, Chun-Jen Liu
- Clin Mol Hepatol. 2023;29(2):320-331. Published online February 1, 2023
-
View: 5452 Download: 361 Web of Science: 14 Crossref: 18
- Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
- Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J. Tuñón, Javier González-Gallego, José L. Mauriz
- Clin Mol Hepatol. 2023;29(2):293-319. Published online February 1, 2023
-
View: 4230 Download: 111 Web of Science: 4 Crossref: 5
- Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
- Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan
- Clin Mol Hepatol. 2023;29(2):277-292. Published online January 30, 2023
-
View: 6648 Download: 495 Web of Science: 14 Crossref: 18
- The role of different viral biomarkers on the management of chronic hepatitis B
- Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(2):263-276. Published online January 19, 2023
-
View: 5008 Download: 304 Web of Science: 8 Crossref: 10
- Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- Clin Mol Hepatol. 2023;29(2):252-262. Published online March 10, 2023
-
View: 4414 Download: 240 Web of Science: 12 Crossref: 15
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
- Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
- Clin Mol Hepatol. 2023;29(2):242-251. Published online March 20, 2023
-
View: 4543 Download: 219 Web of Science: 3 Crossref: 5
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
- Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu
- Clin Mol Hepatol. 2023;29(2):230-241. Published online January 30, 2023
-
View: 5660 Download: 364 Web of Science: 9 Crossref: 9
- Clinical practice guidelines and real-life practice on hepatocellular carcinoma: A the Hong Kong perspective
- Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(2):217-229. Published online December 28, 2022
-
View: 5490 Download: 241 Web of Science: 6 Crossref: 10
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
- Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
- Clin Mol Hepatol. 2023;29(2):206-216. Published online December 22, 2022
-
View: 6071 Download: 437 Web of Science: 26 Crossref: 25
- Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
- Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
- Clin Mol Hepatol. 2023;29(2):197-205. Published online January 5, 2023
-
View: 4421 Download: 226 Web of Science: 11 Crossref: 10
- Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
- Karim Seif El Dahan, Darine Daher, Amit G. Singal
- Clin Mol Hepatol. 2023;29(Suppl):S207-S219. Published online September 14, 2022
-
View: 7434 Download: 163 Web of Science: 5 Crossref: 8
- Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- Clin Mol Hepatol. 2023;29(Suppl):S220-S227. Published online November 10, 2022
-
View: 3604 Download: 133 Web of Science: 2 Crossref: 2
- Non-alcoholic fatty liver disease: the pathologist’s perspective
- Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
- Clin Mol Hepatol. 2023;29(Suppl):S302-S318. Published online November 15, 2022
-
View: 5278 Download: 274 Web of Science: 9 Crossref: 8
- Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
- Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
- Clin Mol Hepatol. 2023;29(Suppl):S157-S170. Published online November 22, 2022
-
View: 4051 Download: 302 Web of Science: 16 Crossref: 14
- Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
- Peter Konyn, Aijaz Ahmed, Donghee Kim
- Clin Mol Hepatol. 2023;29(Suppl):S43-S57. Published online November 22, 2022
-
View: 4052 Download: 162 Web of Science: 17 Crossref: 17
- MAFLD: How is it different from NAFLD?
- Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
- Clin Mol Hepatol. 2023;29(Suppl):S17-S31. Published online November 29, 2022
-
View: 13476 Download: 1,072 Web of Science: 64 Crossref: 80
- Screening strategy for non-alcoholic fatty liver disease
- Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
- Clin Mol Hepatol. 2023;29(Suppl):S103-S122. Published online November 30, 2022
-
View: 4876 Download: 230 Web of Science: 12 Crossref: 14
- Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
- Silvia Sookoian, Carlos J. Pirola
- Clin Mol Hepatol. 2023;29(Suppl):S184-S195. Published online December 5, 2022
-
View: 3938 Download: 177 Web of Science: 9 Crossref: 12
- Comparison between obese and non-obese nonalcoholic fatty liver disease
- Wah-Kheong Chan
- Clin Mol Hepatol. 2023;29(Suppl):S58-S67. Published online December 5, 2022
-
View: 5312 Download: 263 Web of Science: 15 Crossref: 18
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
09 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
